Baird upgraded McKesson (NYSE:MCK) to outperform from neutral on Thursday, citing the updates the medical distributor gave ...

Drug distributor McKesson Corp raised its annual profit forecast on Wednesday, driven by increased sales in its U.S.

Shares of McKesson climbed after the drug distributor raised its fiscal-year guidance and reported strong sales growth during its fiscal second quarter. The stock was up 11%, at $610.99, in midday ...

McKesson's earnings for its fiscal 2025 second quarter exceeded expectations, despite special charges that cut into net ...

An arm of health care giant McKesson will pay $448,578 in back wages and interest as part of an agreement with the U.S.

Steve Baxter, an analyst from Wells Fargo, maintained the Hold rating on McKesson (MCK – Research Report). The associated price target ...

TD Cowen analyst Charles Rhyee raised the firm’s price target on McKesson (MCK) to $651 from $642 and keeps a Buy rating on the shares.

The health care giant agreed to pay $448,000 in back wages to resolve hiring discrimination allegations at a DFW facility.

McKesson Corp (MCK) reports a 21% revenue increase and raises fiscal 2025 EPS guidance amid strategic expansions and ...

McKesson Medical-Surgical Inc. entered into an agreement with the Labor Department on Monday resolving employment ...

Elizabeth Warren seeks scrutiny of deals that would allow drug middlemen McKesson, Cardinal Health, and Cencora to also ...

IRVING, Texas (AP) — IRVING, Texas (AP) — McKesson Corp. (MCK) on Wednesday reported fiscal second-quarter net income of $241 million. The Irving, Texas-based company said it had net income of $1.87 ...